doiSerbia

Prevalence of S and Z alpha 1-antitrypsin mutations in patients with pancreatic diseases in Serbian population

Nikolić Aleksandra (Institut za molekularnu genetiku i genetičko inženjerstvo, Beograd)
Divac Aleksandra (Institut za molekularnu genetiku i genetičko inženjerstvo, Beograd)
Stanković Marija (Institut za molekularnu genetiku i genetičko inženjerstvo, Beograd)
Dinić Jelena (Institut za molekularnu genetiku i genetičko inženjerstvo, Beograd)
Lukić Snežana (Klinika za gastroenterologiju i hepatologiju, Klinički Centar Srbije, Beograd)
Anđelić-Jelić Marina (Klinicko odeljenje za endokrinologiju, dijabetes i bolesti metabolizma, Kliničko bolnički centar Zvezdara, Beograd)
Popović Dragan (Klinika za gastroenterologiju i hepatologiju, Klinički Centar Srbije, Beograd)
Radojković Dragica (Institut za molekularnu genetiku i genetičko inženjerstvo, Beograd)

One of the key points in research of pancreatic disease pathology is further elucidation of the role of proteases and antiproteases, since their imbalance can lead to pancreatic injury. Alpha 1-antitrypsin (AAT) is one of the most important serum inhibitors of proteolytic enzymes, including pancreatic enzymes trypsin, chymotrypsin and elastase. It is speculated that mutations in the AAT gene may influence the onset and the development of pancreatic disease. The presence of the most common AAT mutations Z and S was analyzed in 160 patients with pancreatic diseases (50 patients with pancreatic cancer, 50 patients with chronic pancreatitis and 60 patients with type 2 diabetes mellitus) and 129 healthy individuals by PCR-mediated site-directed mutagenesis (PSM) method. One patient with pancreatic cancer was found to be a carrier of Z mutation, as well as one patient with type 2 diabetes mellitus. One patient with chronic pancreatitis was found to be a carrier of S mutation. The common AAT mutations were statistically significantly over-represented in patients with pancreatic diseases (3 of 160 patients, allelic frequency 0.9%) than in the control group (1 of 129 individuals, allelic frequency 0.4%). The results of this study, requiring confirmation, suggest that common AAT mutations Z and S may be associated with a modest increase in susceptibility to the development of pancreatic disease.

Keywords: alpha 1-anitripsin, pancreatic cancer, chronic pancreatitis, diabetes mellitus type 2, Z and S mutations